drugset / Trial / NCT03865888

Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

NCT03865888

Phase 3 Completed 60 enrolled Pavly Moawd
RandomizedParallel-groupSingle-blindTreatment

Summary

Evaluation of the effect of topical application of Tacrolimus 0.03% (FK506) eye drops versus Cyclosporine 0.05% eye drops in treatment of dry eye in Secondary Sjogren Syndrome.

Timeline

Start
2018-10-30
Primary completion
2019-02-01
Completion
2019-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide 0.05 % Topical
Comparator Tacrolimus Small molecule 0.03 % Topical